This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Saint Luke's Hospital Unveils Neuroscience Institute

The research ultimately resulted in Saint Luke's being named the first Stroke Solution Site by GE's Healthymagination initiative to improve world health which was published in the medical journal Stroke, December 2012.  Saint Luke's data was rigorously reviewed by Oxford Analytica demonstrating how SLNI's coordinated use of people, process and technology yields dramatically better outcomes for stroke patients.

The fundraising campaign for SLNI is led by honorary chairs Marshall Dean and Graham Hunt and chairs John MacDonald and Marilyn Rymer, M.D. More than $2.5 million in leadership gifts has been committed by the Deramus Family Foundation, the Hall Family Foundation, and the William T. Kemper Foundation, Commerce Bank, trustee. In addition, proceeds from the Saint Luke's Hospital Auxiliary's Holly Ball fundraiser in December will support SLNI's neurosurgical center. 

About the Saint Luke's Neuroscience Institute

Saint Luke's Neuroscience Institute, a member of Saint Luke's Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of ischemic strokes. Its legacy of innovation began in 1993 when doctors performed one of the world's first intra-arterial stroke reversal procedures. Since then, Saint Luke's specialists have continued to pioneer new stroke treatments and reverse stroke's debilitating effects for thousands of patients, and is one of the world's most experienced and prolific leaders in the use of Tissue Plasminogen Activator (t-PA), a clot-busting medication for treatment of  ischemic stroke.   SLNI, headquartered in Kansas City, Missouri, brings together a team of the country's most accomplished neurologists to provide a comprehensive treatment center for the most complex neurological issues, such as stroke, epilepsy, brain tumors, facial pain, Parkinson's disease, Alzheimer's, headaches, aneurysms, and the latest in minimally invasive spinal surgical techniques.  SLNI's advancements in Neurology have made it a national leader in neurological treatment and care.

SOURCE Saint Luke's Neuroscience Institute

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs